Navigation Links
Injectable CTM Manufacturing Market Report Now Available
Date:9/11/2008

PharmSource Information Services Inc. announces publication of a new report: The Injectable CTM Manufacturing Market; Limited time free report download September 10-15, 2008

Fairfax, VA (PRWEB) September 11, 2008 -- Five years ago only a handful of CROs and CMOs were manufacturing clinical batches of injectables, leaving bio/pharmaceutical companies to scramble for fill/finish capacity. This PharmSource report analyzes the prospect of whether clinical trial materials (CTM) injectable manufacturing capacity may be headed to overcapacity today.

The Injectable CTM Manufacturing Market compares manufacture of drug candidate, development and placebo batch manufacturing needs with projections and manufacturing capacity to illustrate the current supply/demand balance. "This report will provide valuable strategic insight to CTM manufacturers and contract service providers alike," comments PharmSource founder and president, Jim Miller. The $495 report will be offered as a free download to interested parties from September 10th through September 15, 2008 at the PharmSource website : http://www.pharmsource.com/forms.cfm?id=30

About PharmSource
PharmSource Information Services, Inc. is a respected provider of contract drug development and manufacturing intelligence. Since 1996 PharmSource has assisted Biotechnology and Pharmaceutical companies with the implementation and management of sourcing strategies and tactics through insightful publications, analyses and intelligence services. Visit PharmSource on the web at http://www.pharmsource.com or contact them at 703-383-4903.

###

Read the full story at http://www.prweb.com/releases/2008/09/prweb1312084.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Page: 1

Related biology technology :

1. Ranbaxy to Consolidate Position in Biopharmaceuticals and Speciality Injectables Including Oncology
2. Nastech Enters Into Feasibility Study to Develop a Non-Injectable Dosage Form of Factor IX to Control Bleeding
3. Barr Confirms Patent Challenge of Eloxatin(R) Injectable, 5mg/mL
4. Actavis Receives Approval for Irinotecan Hydrochloride Injection; Extends US Portfolio with First Injectable Product
5. Epeius Biotechnologies Awarded U.S. Patent for Targeted Injectable Gene Delivery In Vivo
6. Video: New Survey Shows Three in Four School Nurses Have Students at Risk for Severe Allergic Reactions Who Do Not Bring Auto-Injectable Epinephrine to School
7. SAFC Expands Hi-Potency API Manufacturing and Introduces Solid-Form Testing at Its Madison Facility
8. Middle East Pharma Manufacturing/Biotech is Ready to Boom
9. SAFC Expands European Commercial Manufacturing and Storage Capacities With $10 Million Investment
10. Hyaluron Contract Manufacturing Named a 2007 Economic Impact Award Finalist
11. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , ... June 27, 2016 , ... Parallel 6 ... trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module which ... with the physician and clinical trial team. , Using the CONSULT module, patients and ...
(Date:6/27/2016)... 27, 2016  Liquid Biotech USA ... of a Sponsored Research Agreement with The University ... (CTCs) from cancer patients.  The funding will be ... correlate with clinical outcomes in cancer patients undergoing ... then be employed to support the design of ...
(Date:6/24/2016)... DIEGO , June 24, 2016 ... more sensitively detects cancers susceptible to PARP inhibitors ... circulating tumor cells (CTCs). The new test has ... HRD-targeted therapeutics in multiple cancer types. ... targeting DNA damage response pathways, including PARP, ATM, ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a ... eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research ... by providing practical tips, tools, and strategies for clinical researchers. , “The landscape ...
Breaking Biology Technology:
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
(Date:4/28/2016)... Sweden , April 28, 2016 First ... M (139.9), up 966% compared with the first quarter of 2015 ... profit totaled SEK 589.1 M (loss: 18.8) and the operating margin ... 7.12 (loss: 0.32) Cash flow from operations was SEK ... The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
(Date:4/19/2016)... 2016 The new GEZE SecuLogic ... web-based "all-in-one" system solution for all door components. It ... the door interface with integration authorization management system, and ... The minimal dimensions of the access control and the ... installations offer considerable freedom of design with regard to ...
Breaking Biology News(10 mins):